Adipokines, cytokines and body fat stores in hepatitis C virus liver steatosis

Table 1 Differences in biochemical variables, body mass index and total lean and total fat area between patients and controls

	Patients		Controls
	n	X ± SD, median (IQ range)	n	X ± SD, median (IQ range)
Insulin (μU/mL)	44	12.48 ± 15.65, 7.89 (4.63-14.32)	10	8.34 ± 4.34, 7.15 (5.08-10.63)	Z = 0.43; NS
Resistin (ng/mL)	44	4.97 ± 1.76, 4.90 (3.98-5.60)	10	4.28 ± 1.42, 4.97 (3.32-5.29)	Z = 0.88; NS
Adiponectin (ng/mL)	44	11.99 ± 8.30, 9.54 (6.04-17.16)	16	24.92 ± 21.84, 19.05 (13.53-21.58)	Z = 3.18; P = 0.001
Leptin (ng/mL)	44	12.25 ± 15.83, 4.23 (1.15-17.78)	10	18.41 ± 16.03, 12.89 (4.65-34.42)	Z = 1.78; NS
Tumor necrosis factor-α (pg/mL)	56	10.65 ± 4.14, 10.18 (7.15-13.08)	19	6.05 ± 1.90, 5.20 (4.40-8.00)	Z = 4.56; P < 0.001
Interleukin-6 (pg/mL)	53	4.28 ± 4.75, 2.0 (2.0-4.29)	19	5.90 ± 1.64, 5.0 (5.0-6.60)	Z = 2.97; P = 0.003
Body mass index (kg/m2)	56	24.19 ± 3.44	19	25.20 ± 3.42	t = 1.02; NS
Total fat mass (g)	50	19929 ± 11944	19	21443 ± 6393	t = 0.54; NS
Total lean mass (g)	50	48284 ± 8848	19	50131 ± 15796	t = 0.64; NS

Comparisons were made using non-parametric tests, such as Mann-Whitney’s U test (Z) or parametric ones (Student’s t-test). NS: Not significant.